57
Participants
Start Date
October 17, 2016
Primary Completion Date
January 29, 2018
Study Completion Date
January 29, 2018
Placebo
PF-06649751
Sentara Neurology Specialists, Virginia Beach
Asheville Neurology Specialists PA, Asheville
Atlanta Center for Medical Research, Atlanta
University of Miami, Miami
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
University of South Florida Carol and Frank Morsani Center for Advanced Health Care, Tampa
University of South Florida Faculty Office Building, Tampa
University of South Florida, Tampa
University of South Florida Parkinson's Disease and Movement Disorders Center, Tampa
Paracelsus-Elena-Klinik Kassel, Kassel
Universitätsklinikum Gießen und Marburg GmbH, Marburg
CHU de Grenoble Alpes, Grenoble
CHU Grenoble Alpes, La Tronche
University of Toledo, Gardner-McMaster Parkinson Center, Toledo
University of Toledo, Toledo
Cleveland Clinic, Cleveland
St. Josef Hospital GmbH, Bochum
Edith Wolfson Medical Center, Holon
Pharmacy, Edith Wolfson Medical Center, Holon
Rush University Medical Center, Chicago
University of Kansas Medical Center, Kansas City
University hospital Tuebingen, Tübingen
Hopital Pitie Salpetriere, Paris
AS Clinical Research Consultants of North Texas, PLLC, Greenville
Baylor College of Medicine, Houston
Klinik Haag i. OB, Haag I. OB
St Joseph's Hospital and Medical Center, Barrow Neurology Clinics, Phoenix
St. Joseph's Hospital and Medical Center, Phoenix
Universitaetsklinik Ulm, Ulm
Hopital Henri Mondor, Créteil
Hôpital Henri Mondor, Créteil
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Hospital de La Timone, Marseille
Hospital La Timone, Marseille
Hopital Pitie-Salpetriere, Paris
Praxis Oehlwein Outpatient clinic for PD, DBS, Movement Disorders, Gera
Lead Sponsor
Pfizer
INDUSTRY